NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide.

Author(s): Holt RI, Erotokritou-Mulligan I, Ridley SA, McHugh CM, Bassett EE, Cowan DA, Bartlett C, Sönksen PH

Publication: Growth Horm IGF Res, 2009, Vol. 19, Page 43-50

PubMed ID: 18617430 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of anticoagulant, collection of serum rather than plasma, and storage as blood, serum or plasma on levels of insulin-like growth factor-I (IGF-I) and type III procollagen peptide (P-III-P).

Conclusion of Paper

P-III-P concentrations rose with room temperature storage of clotted-blood, lithium-heparin blood, lithium-heparin plasma or serum. However, room temperature storage did not affect P-III-P concentrations in EDTA-plasma. Storage of any specimen type at 4 degrees C had no effect on P-III-P levels, and neither storage temperature affected IGF-I levels. P-III-P concentrations in EDTA-plasma were higher than those in lithium-heparin plasma or serum, but IGF-I levels were comparable between serum, EDTA-plasma and lithium-heparin plasma.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of storage as blood, plasma or serum on levels of IGF-I and P-III-P in serum, lithium heparin-plasma and EDTA-plasma. Whole blood was centrifuged within 1 h or after experimental storage, and serum or plasma was stored frozen at -80 degrees C for up to 2 months prior to analysis. Two different immunoradiometric assays (IRMA) were used to measure IGF-I and concentrations of P-III-P, and some serum specimens were verified by radioimmunoassay (RIA).

    Summary of Findings:

    P-III-P concentrations rose by 6.5%, 6.2%, 7.0% and 6.5% with storage of clotted-blood (p=0.006), lithium-heparin blood (p=0.001), lithium-heparin plasma (p=0.002) or serum (p<0.001) at room temperature, respectively, but P-III-P concentrations were not affected by storage at 4 degrees C. The increase in serum P-III-P levels with storage at room temperature was confirmed using an RIA. P-III-P concentrations in EDTA-plasma were unaffected by storage at room temperature and were higher than those in lithium-heparin plasma or serum. IGF-I levels were comparable between serum, EDTA-plasma and lithium-heparin plasma, and up to 5 days of storage at room temperature or 4 degrees C had no effect on IGF-I concentrations. The intra-individual variability in IGF-I and P-III-P concentrations after storage was 5.5% and 25.9%, respectively, but the intra-individual variability of specimens centrifuged immediately and frozen was 3.9% and 4.1%, respectively.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein Immunoradiometric assay
    Peptide Immunoradiometric assay
    Peptide Radioimmunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage temperature Room temperature
    4 degrees C
    Storage Storage duration <1 h
    1 day
    2 days
    3 days
    4 days
    5 days
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Whole blood
    Immunoradiometric assay Specific Technology platform RIA
    Biospecimen Acquisition Anticoagulant EDTA
    Lithium heparin
    None
    Biospecimen Aliquots and Components Centrifugation Centrifugation delays investigated

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...